Press Room – Jacinto Convit World Organization

End of year bulletin: Our journey in 2025

We sincerely thank our allies, donors, collaborators, staff, and everyone who supported us throughout 2025. This year brought valuable opportunities to reinforce our efforts and continue building on the foundation of our mission.

Science Series #21: Artificial intelligence in early cancer detection

One of the most widely studied applications of AI in oncology is in medical imaging. AI, particularly deep learning algorithms, has been trained to recognize minute patterns in mammograms, CT scans, MRIs, and dermoscopic images that may indicate early cancerous changes.

Structuring a BALB/c mice colony in the Unidad Experimental de Inmunoterapia of Fundación Jacinto Convit – Venezuela

Animal models are a fundamental part of preclinical scientific research in the development of new therapies, including drugs and gene therapies. For such purposes, it is crucial to have an animal model that aligns with the study being conducted.

End of year bulletin: Our journey in 2024

JCWO´s mission is to provide free access to modern diagnostics and innovative treatments to those who need it most, while training new generations of professionals.

Charity Cocktail Reception with Music, Comedy, and Science

Jacinto Convit World Organization (JCWO) invites you to an exclusive charity event to be held at the charming Gisselle restaurant, located in the heart of Madrid, Spain, on Tuesday, November 19, 2024.

Breast cancer immunotherapy: Realities and advances

Breast cancer is the most common malignant tumor and the main cause of death in women worldwide. With increased knowledge regarding tumor escape mechanisms and advances in immunology, many new antitumor strategies make immunotherapy a promising approach for the treatment of this disease.

ArtSale for a cause

By purchasing the art donated by Juan Gerstl, your contribution will make an impact on the lives of 200 vulnerable cancer patients in Venezuela, improving their survival rate, prognosis, and response to treatment.

Science Series #20: The role of the microbiome in Alzheimer´s disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that is characterized by loss of memory, cognitive and behavioral skills, and many neuropsychiatric comorbidities, such as depression and sleep disorders.

Science Series #19: Switchable CAR-T cells therapy

CAR-T cell therapy involves taking a patient’s immune cells (T cells), and engineering them in a laboratory to produce a special structure called a Chimeric Antigen Receptor (CAR). This structure enables the T cells to recognize and attack cancer cells.